IRIS
RIVARA, Mirko
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.314
AS - Asia 2.217
EU - Europa 1.890
SA - Sud America 251
AF - Africa 134
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 6.808
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.238
SG - Singapore 749
CN - Cina 693
IT - Italia 403
VN - Vietnam 347
FI - Finlandia 297
SE - Svezia 245
IE - Irlanda 232
DE - Germania 196
BR - Brasile 191
HK - Hong Kong 185
UA - Ucraina 142
NL - Olanda 83
GB - Regno Unito 76
ZA - Sudafrica 73
FR - Francia 71
RU - Federazione Russa 62
CA - Canada 51
TR - Turchia 42
IN - India 36
CI - Costa d'Avorio 25
BD - Bangladesh 22
KR - Corea 22
JP - Giappone 19
PH - Filippine 19
AR - Argentina 18
MX - Messico 17
CZ - Repubblica Ceca 16
IQ - Iraq 16
BE - Belgio 15
PL - Polonia 12
EC - Ecuador 11
TH - Thailandia 11
CO - Colombia 9
EG - Egitto 8
ES - Italia 8
ID - Indonesia 8
PK - Pakistan 8
CL - Cile 7
LT - Lituania 7
MA - Marocco 7
TN - Tunisia 7
VE - Venezuela 7
AT - Austria 6
JO - Giordania 6
PT - Portogallo 6
TW - Taiwan 4
AL - Albania 3
AZ - Azerbaigian 3
BO - Bolivia 3
ET - Etiopia 3
IR - Iran 3
NP - Nepal 3
PY - Paraguay 3
SA - Arabia Saudita 3
AM - Armenia 2
CR - Costa Rica 2
KE - Kenya 2
KW - Kuwait 2
LY - Libia 2
NI - Nicaragua 2
PE - Perù 2
PS - Palestinian Territory 2
QA - Qatar 2
SN - Senegal 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CY - Cipro 1
DZ - Algeria 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
LI - Liechtenstein 1
LV - Lettonia 1
MD - Moldavia 1
MU - Mauritius 1
MY - Malesia 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
Totale 6.808
Salva come PNG Salva come JPEG
Città #
Singapore 393
Ashburn 290
Dublin 232
Chandler 226
San Jose 183
Hong Kong 174
Beijing 171
Jacksonville 154
Santa Clara 143
Dallas 113
Ann Arbor 97
Ho Chi Minh City 97
Parma 93
Boardman 89
Hanoi 86
Johannesburg 71
Munich 71
Hefei 69
Dearborn 67
Nanjing 62
New York 54
Los Angeles 52
Milan 51
Shanghai 51
Lauterbourg 45
Princeton 45
Chicago 34
Helsinki 34
Wilmington 32
Izmir 31
San Mateo 29
Moscow 26
Toronto 26
Abidjan 25
Frankfurt am Main 25
Turku 24
London 20
Council Bluffs 19
Seoul 19
Shenyang 18
Guangzhou 17
Nanchang 17
Seattle 17
Tokyo 17
Buffalo 16
Columbus 16
Da Nang 16
Haiphong 16
Jinan 16
Kunming 16
São Paulo 15
Bremen 14
Brussels 14
Des Moines 14
Hebei 14
The Dalles 13
Jiaxing 11
Brno 10
Brooklyn 10
Chennai 10
Modena 10
Reggio Emilia 10
Woodbridge 10
Bologna 9
Warsaw 9
Amsterdam 8
Changsha 8
Montreal 8
Nuremberg 8
Tianjin 8
Baghdad 7
Bengaluru 7
Ankara 6
Atlanta 6
Belo Horizonte 6
Chengdu 6
Jakarta 6
Mexico City 6
Ottawa 6
Piacenza 6
Stockholm 6
Vienna 6
Amman 5
Auburn Hills 5
Falls Church 5
Genoa 5
Hangzhou 5
Manchester 5
Norwalk 5
Quito 5
Redondo Beach 5
Thái Bình 5
Tunis 5
Abbiategrasso 4
Brescia 4
Bắc Ninh 4
Calgary 4
Düsseldorf 4
Miami 4
Ninh Bình 4
Totale 4.075
Salva come PNG Salva come JPEG
Nome #
Chemico-Physical Properties of Some 1,1′-Bis-alkyl-2,2′-hexane-1,6-diyl-bispyridinium Chlorides Hydrogenated and Partially Fluorinated for Gene Delivery 199
Gene-Delivery Ability of New Hydrogenated and Partially Fluorinated Gemini bispyridinium Surfactants with Six Methylene Spacers 199
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line 191
Synthesis, biological activity, QSAR and QSPR study of 2/aminobenzimidazole derivatives as potent H3-antagonists 190
NEW ALKBH2 AND ALKBH5 INHIBITORS FOR TREATING GLIOBLASTOMA 186
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line 179
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 174
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 169
Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists 163
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 162
A Short and Efficient Synthesis of the Selective H4 Receptor Agonist 4-Methylhistamine 157
QSAR study of 2-aminobenzimidazole derivatives as H3 antagonists 156
Chiral NMR discrimination of the diastereoisomeric salts of the H(3)-antagonist 2-[3-(1H-imidazol-4-ylmethyl)piperidin-1-yl]-1H-benzimidazole. 154
COMPOSITIONS AND METHODS FOR BLOCKING SODIUM CHANNELS 153
COMPOSITIONS AND METHODS FOR BLOCKING SODIUM CHANNELS 149
Antioxidant and cytoprotective activity of indole derivatives related to melatonin 148
2,4(5)-Diarylimidazoles: Synthesis and Biological Evaluation of a New Class of Sodium Channel Blockers against hNav1.2 147
Development and validation of a LC-MS method with electrospray ionization for the determination of the imidazole H(3) antagonist ROS203 in rat plasma. 146
Advances in Design and Development of Sodium Channel Blockers. 145
MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines 145
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma 144
2,4(5)-Diarylimidazoles as Inhibitors of hNaV1.2 Sodium Channels: Pharmacological Evaluationand Structure-Property Relationships 144
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 140
Anticonvulsant Activity of 2,4(5)-Diarylimidazoles in Mice and Rat Models 139
Anticonvulsant Activity of 2,4(1H)-Diarylimidazoles in Mice and Rats Acute Seizure Models 138
Development of a GPCR model for SAR interpretation of classical and new H3 antagonists 138
COMPOSITIONS AND METHODS FOR BLOCKING SODIUM CHANNELS 138
Novel Sodium Channel Antagonists in the Treatment of Neuropathic Pain 136
Biological evaluation of imidazobenzoxazines, imidazobenzoxazin-5-ones and imidazobenzoxazin-5-thiones as sodium channel blockers 135
Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design 131
Drug repurposing approaches to fight Dengue virus infection and related diseases 127
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 127
Synthesis, antioxidant activity and structure-activity relationships for a new series of 2-(N-acylaminoethyl)indoles with melatonin-like cytoprotective activity 119
Synthesis and biological evaluation of new non-imidazole H(3)-receptor antagonists of the 2-aminobenzimidazole series 119
Potential in-vitro antiviral activity of MV1035 on SARS-CoV-2 wild type viruses 117
In vivo Screening of Diarylimidazoles as Anticonvulsant Agents 112
NMR Analysis of a Series of Imidazobenzoxazines 110
A Practical Synthesis of 2,4(5)-Diarylimidazoles from Simple Building Blocks 110
Inhibition of NaV1.6 sodium channel currents by a novel series of 1,4-disubstituted-triazole derivatives obtained via copper-catalyzed click chemistry 110
IMIDAZOBENZOXAZIN-5-THIONE (MV1035) TO OVERCOME THE BLOOD-BRAIN BARRIER AND TARGET CNS DISEASES 109
Imidazole H3-antagonists: Relationship between Structure and Ex-vivo binding to Rat Brain H3-Receptors 107
Sodium Channel Blocking Activity and In-vivo Testing of New Phenyl-imidazole Derivatives. 107
Microwave Assisted Efficient Synthesis of Imidazole-based Privileged Structure 103
Recent Advances in the Medicinal Chemistry of Sodium Channel Blockers and their Therapeutic Potential 101
Sodium channel blockers: a patent review (2010 - 2014) 101
Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptor. 98
Sodium Channel Blockers as Therapeutic Target for Treating Epilepsy: Recent Updates 96
Sodium channel blockers for neuropathic pain. 93
NaV1.1 and NaV1.6 selective compounds reduce the behavior phenotype and epileptiform activity in a novel zebrafish model for Dravet syndrome 87
Subtype-selective small molecule inhibitors reveal a fundamental role for Nav1.7 in nociceptor electrogenesis, axonal conduction and presynaptic release 70
Recent advances in the discovery of ALKBH 1–8 inhibitors. 61
Totale 6.879
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.715
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.715
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202162 0 0 0 0 0 0 0 0 0 16 42 4
2021/2022229 3 2 5 18 14 7 29 26 21 17 17 70
2022/2023929 106 108 68 57 71 118 17 44 275 12 36 17
2023/2024411 22 32 11 14 43 84 38 29 19 21 35 63
2024/20251.277 64 78 99 90 72 137 41 77 101 114 128 276
2025/20262.676 251 291 359 305 396 171 305 90 328 180 0 0
Totale 6.879